News | March 12, 2015

Novel Thrombectomy Device Removes Large Blood Clots From Patient's Veins

Aspire system used to treat occluded inferior vena cave, deep vein thrombosis

Aspire, Pablo Uceda, DFW Vascular, deep vein thrombosis, thrombectomy

March 12, 2015 — Pablo Uceda, M.D., vascular surgeon with DFW Vascular, Dallas, Texas, was successful in using a new device to clear blood clots out of a patient's legs.

The patient presented with an occluded inferior vena cava and a deep vein thrombosis. The blood clots caused swelling and pain in the legs and potentially could migrate to other areas of the body including the lungs, which can be life-threatening. Removing all of the blood clots quickly is important.

Uceda first infused tissue plasminogen activator (tPA), a thrombolytic agent, into the veins then performed angioplasty. Once angioplasty was performed the clots in the veins were broken up and needed to be removed. Uceda then used the Aspire Mechanical Thrombectomy system to remove the blood clots.

"Removing large blood clots is not easy to do. Many available devices are not able to remove the entire clot, leaving residual clot behind," said Uceda. "The Aspire Mechanical Thrombectomy device has a high aspiration force; this allowed me to remove the entire clot."

The Aspire Mechanical Thrombectomy System allows clinicians to instantly start, stop, increase, decrease, pulse or maintain thrombectomy force during a procedure. Aspire Mechanical Aspirators also aspirate up to 280ml, almost 10 times more than basic syringe-based systems, without multiple messy and time-consuming catheter connections, disconnections, and re-connections to improve speed and performance.

The Aspire Mechanical Thrombectomy System is available by itself or in kits that include an over-the-wire or rapid exchange thrombectomy catheter. Aspire Mechanical Aspirators may also be connected to any thrombectomy catheter the clinician chooses. 

For more information: www.controlmedtech.com

Related Content

ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
NICE, U.K., edoxaban, Lixiana, VTE, venous thromboembolism, deep vein thrombosis, pulmonary embolism
News | Deep Vein Thrombosis| August 12, 2015
The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients suffering...
Overlay Init